Greenwood Capital Associates LLC Lowers Position in Schrödinger, Inc. (NASDAQ:SDGR)

Greenwood Capital Associates LLC lessened its position in Schrödinger, Inc. (NASDAQ:SDGRFree Report) by 3.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 22,558 shares of the company’s stock after selling 709 shares during the quarter. Greenwood Capital Associates LLC’s holdings in Schrödinger were worth $418,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Harbor Capital Advisors Inc. lifted its stake in shares of Schrödinger by 5.0% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 13,059 shares of the company’s stock valued at $242,000 after purchasing an additional 622 shares during the period. Stephens Investment Management Group LLC lifted its stake in shares of Schrödinger by 39.6% in the 3rd quarter. Stephens Investment Management Group LLC now owns 1,539,870 shares of the company’s stock valued at $28,565,000 after purchasing an additional 436,789 shares during the period. Private Advisor Group LLC lifted its stake in shares of Schrödinger by 20.5% in the 3rd quarter. Private Advisor Group LLC now owns 12,150 shares of the company’s stock valued at $225,000 after purchasing an additional 2,065 shares during the period. SG Americas Securities LLC purchased a new position in shares of Schrödinger in the 3rd quarter valued at approximately $313,000. Finally, Creative Planning purchased a new position in shares of Schrödinger in the 2nd quarter valued at approximately $425,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SDGR. KeyCorp lowered their target price on Schrödinger from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, July 11th. BMO Capital Markets reduced their price objective on Schrödinger from $30.00 to $25.00 and set an “outperform” rating for the company in a research report on Thursday, October 17th. Finally, Morgan Stanley reduced their price objective on Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 21st. Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $32.60.

Read Our Latest Report on SDGR

Insiders Place Their Bets

In other Schrödinger news, insider Margaret Dugan sold 1,531 shares of Schrödinger stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $17.78, for a total value of $27,221.18. Following the completion of the sale, the insider now owns 13,469 shares of the company’s stock, valued at approximately $239,478.82. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 8.60% of the company’s stock.

Schrödinger Trading Down 1.9 %

Schrödinger stock opened at $17.89 on Wednesday. The firm has a market cap of $1.30 billion, a price-to-earnings ratio of -6.68 and a beta of 1.50. The stock has a fifty day simple moving average of $18.91 and a two-hundred day simple moving average of $20.61. Schrödinger, Inc. has a 12 month low of $16.67 and a 12 month high of $38.00.

Schrödinger Company Profile

(Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Further Reading

Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrödinger, Inc. (NASDAQ:SDGRFree Report).

Institutional Ownership by Quarter for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.